# Effect of Abaloparatide on Lumbar Disc Degeneration

> **NCT03708926** · PHASE2 · WITHDRAWN · sponsor: **Johns Hopkins University**

## Conditions studied

- Degeneration Disc Intervertebral

## Interventions

- **DRUG:** Abaloparatide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03708926
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-03
- **Primary completion:** 2023-08
- **Final completion:** 2024-02
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Inability to obtain drugs from supplier.
- **Last updated:** 2021-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03708926

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03708926, "Effect of Abaloparatide on Lumbar Disc Degeneration". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03708926. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*